How many studies have been conducted on 1 5 Isoquinolinesulfonyl 2 Methylpiperazine?

BiohacksAI has indexed 300 PubMed studies on 1 5 Isoquinolinesulfonyl 2 Methylpiperazine. 1% of studies involve human subjects.

What are the main research areas for 1 5 Isoquinolinesulfonyl 2 Methylpiperazine?

The primary research domains for 1 5 Isoquinolinesulfonyl 2 Methylpiperazine are 🦴 Bone & Joint, 🔬 Oncology, 🧠 Focus & Attention. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

1 5 Isoquinolinesulfonyl 2 Methylpiperazine

A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.

300+ PubMed studies analyzed · Evidence Score: 39.6

Research Domains

1 5 Isoquinolinesulfonyl 2 Methylpiperazine has been studied across 24 research domains including 🦴 Bone & Joint, 🔬 Oncology, 🧠 Focus & Attention, 🔬 Inflammation, 🔥 Metabolic. The primary research focus is 🦴 Bone & Joint with 32% of studies addressing this area.

Loading evidence profile...

This evidence profile for 1 5 Isoquinolinesulfonyl 2 Methylpiperazine is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.